###begin article-title 0
A PP1-binding motif present in BRCA1 plays a role in its DNA repair function
###end article-title 0
###begin p 1
Conflict of Interest: The authors have declared that no conflict of interest exists.
###end p 1
###begin p 2
###xml 109 112 101 104 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">898</sup>
###xml 116 119 108 111 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">901</sup>
###xml 326 331 <span type="species:ncbi:10090">mouse</span>
###xml 400 405 <span type="species:ncbi:302767">comet</span>
Protein phosphatase 1alpha (PP1alpha) regulates phosphorylation of BRCA1, which contains a PP1-binding motif 898KVTF901. Mutation of this motif greatly reduces the interaction between BRCA1 and PP1alpha. Here we show that mutation of the PP1-binding motif abolishes the ability of BRCA1 to enhance survival of Brca1-deficient mouse mammary tumor cells after DNA damage. The Rad51 focus formation and comet assays revealed that the DNA repair function of BRCA1 was impaired when the PP1-binding motif was mutated. Analysis of subnuclear localization of GFP-tagged BRCA1 demonstrated that mutation of the PP1-binding motif affected BRCA1 redistribution in response to DNA damage. BRCA1 is required for the formation of Rad51 subnuclear foci after DNA damage. Mutation of the PP1-binding motif in BRCA1 also affected recruitment of Rad51 to sites of DNA damage. Consistent with these findings, knockdown of PP1alpha in BRCA1-proficient cells by small interfering RNA also significantly reduced Rad51 focus formation induced by DNA damage. Further analysis indicated that mutation of the PP1-binding motif compromised BRCA1 activities in homologous recombination. Altogether, our data implicate that interaction with PP1alpha is important for BRCA1 function in DNA repair.
###end p 2
###begin title 3
1. Introduction
###end title 3
###begin p 4
###xml 69 74 69 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 149 154 149 154 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 215 216 215 216 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</sub>
###xml 214 216 214 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M<sub>r</sub></italic>
###xml 530 531 530 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 532 533 532 533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 17 22 <span type="species:ncbi:9606">human</span>
Mutations of the human breast and ovarian cancer susceptibility gene BRCA1 account for the majority of familial breast and ovarian cancer cases. The BRCA1 gene encodes a nuclear phosphoprotein of 1863 amino acids (Mr ~220,000). Accumulated evidence indicates that BRCA1 plays an important role in multiple cellular functions including cell cycle checkpoint control, chromosome remodeling, transcriptional regulation, recombination, and DNA repair; therefore, is crucial for maintaining genomic integrity and chromosomal stability 1-3.
###end p 4
###begin p 5
###xml 111 112 111 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 113 114 113 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 383 384 383 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 385 386 385 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 410 412 410 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 506 508 506 508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 524 526 524 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 621 622 621 622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 623 625 623 625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
BRCA1 is expressed and phosphorylated in a cell cycle-dependent manner and is mainly phosphorylated in S phase 4,5. BRCA1 is also phosphorylated by checkpoint kinases, including hCds1/Chk2, ATM, and ATR, in response to DNA damage induced by ionizing radiation (IR), UV or chemicals. Phosphorylation of BRCA1 occurs at multiple serine residues, such as S1524 and S1423 by ATM and ATR 6-9 and S988 by hCds1/Chk2 10. The phosphorylation state of BRCA1 is important for its function in G2/M checkpoint control 11 and DNA repair 12. However, BRCA1 is primarily hypophosphorylated in mitosis and G0/G1 phases of the cell cycle 5,13, suggesting that BRCA1 must undergo dephosphorylation during G2/M transition. Whether or not dephosphorylation of BRCA1 is critical for its function remains unclear.
###end p 5
###begin p 6
###xml 345 347 345 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 424 426 424 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 442 444 442 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 500 502 500 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 696 698 692 694 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 699 701 695 697 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
Serine/threonine protein phosphatase 1 (PP1) holoenzymes consist of catalytic subunits and regulatory subunits which target the catalytic subunits to distinct subcellular localizations. Together, the PP1 complexes regulate diverse cellular functions including cell cycle progression, chromosome segregation, cytokinesis, and cellular metabolism 14. Recent studies also indicate that PP1 is involved in checkpoint activation 15 and DNA repair 16, as well as recovery from DNA damage checkpoint arrest 17. We previously reported that the PP1alpha catalytic subunit interacts with BRCA1 and dephosphorylates the protein at multiple serine residues that are phosphorylated by hCds1/Chk2, ATM and ATR 18,19. Thus, PP1alpha, one of the three isoforms of the PP1 catalytic subunit (alpha, gamma, and delta), may serve as a general regulator for BRCA1 phosphorylation.
###end p 6
###begin p 7
###xml 326 328 326 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 559 562 559 562 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">898</sup>
###xml 566 569 566 569 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">901</sup>
###xml 675 677 671 673 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 573 578 <span type="species:ncbi:9606">human</span>
Proteins interacting with the PP1 catalytic subunit, including the majority of regulatory subunits and several substrates, share a consensus PP1-binding motif (R/K)(V/I)xF, which binds to a hydrophobic groove on the surface of the PP1 catalytic subunit and serves as an anchor for the initial binding of these proteins to PP1 14. Mutation of this consensus motif by substitution of phenylalanine with alanine or deletion of the motif greatly reduces the binding between these proteins and the PP1 catalytic subunit. We recently identified a PP1-binding motif 898KVTF901 in human BRCA1. eMutation of this motif substantially reduces the interaction between BRCA1 and PP1alpha 19.
###end p 7
###begin p 8
###xml 146 147 146 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 148 149 148 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 150 152 150 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 234 236 234 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 237 239 237 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 420 422 420 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 469 471 469 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 628 630 628 630 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 641 643 641 643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 692 694 692 694 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 824 826 824 826 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 827 829 827 829 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 948 950 948 950 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 1107 1109 1107 1109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 1171 1173 1171 1173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 1174 1176 1174 1176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 1450 1455 1450 1455 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 1455 1462 1455 1462 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8710;11/&#8710;11</sup>
###xml 1489 1491 1489 1491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 1463 1468 <span type="species:ncbi:10090">mouse</span>
BRCA1 is implicated in the repair of DNA double-strand breaks (DSBs) by either homologous recombination (HR) or non-homologous end-joining (NHEJ) 1,2,20. It has been reported that BRCA1 also participates in nucleotide-excision repair 21,22. Rad51, a homologue of bacterial RecA protein, is involved in the repair of DSBs by HR, which is an error-free DNA repair process. Expression of Rad51 is also cell cycle-dependent 23 and the protein forms nuclear foci in S phase 24. BRCA2 has been shown to interact with Rad51 and regulate the assembly of Rad51 filaments at the sites of DNA repair. BRCA1 forms a complex with both Rad51 25 and BRCA2 26. BRCA1 associates with Rad51 at subnuclear foci 25. After DNA damage, BRCA1 is phosphorylated, relocalizes along with Rad51 to the damaged regions, and displays large nuclear foci 27,28. BRCA1 also associates with the MRE11/RAD50/NBS1 complex, which participates in HR, NHEJ, and the DNA damage response 28. It has been demonstrated that hCds1/Chk2 phosphorylation of BRCA1 regulates the repair of DSBs by promoting error-free HR and suppressing error-prone NHEJ 12. BRCA1 may also participate in an error-free subtype of NHEJ 29,30. Thus, BRCA1 is required for accurate DNA repair and BRCA1-deficient cells are hypersensitive to DNA damaging agents which induce DSBs or crosslinks of DNA strands. Here, we sought to test whether interaction with PP1 was involved in the DNA repair function of BRCA1 using Brca1∆11/∆11 mouse mammary tumor cells 31.
###end p 8
###begin title 9
2. Materials and Methods
###end title 9
###begin title 10
Vector construction
###end title 10
###begin p 11
###xml 34 38 34 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">XhoI</italic>
###xml 39 52 39 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HindIII BRCA1</italic>
###xml 88 93 88 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 308 313 308 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AflII</italic>
###xml 314 321 314 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HindIII</italic>
###xml 448 453 448 453 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 82 87 <span type="species:ncbi:9606">human</span>
To construct pGFPBRCA1, a ~5.6 kb XhoI-HindIII BRCA1 cDNA fragment containing the human BRCA1 cDNA sequence (containing the stop codon) was subcloned into pGFP-C3 (Clontech, Mountain View, CA, USA). The mutant BRCA1 expression vectors, pGFPBRCA1F901A and pGFPBRCA1DEL, were constructed by replacing a 4.2 kb AflII-HindIII fragment in pGFPBRCA1 with the same fragments containing the mutations from modified pBRCA1GFPF901A and pBRCA1GFPDEL with the BRCA1 stop codon. All plasmid clones were sequence-verified.
###end p 11
###begin title 12
Cell culture and transfection
###end title 12
###begin p 13
###xml 37 42 37 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 2 7 <span type="species:ncbi:10090">mouse</span>
###xml 513 518 <span type="species:ncbi:9606">human</span>
A mouse mammary tumor cell line 780 (Brca1 exon 11-deleted), 293T and COS-7 cells were cultured in DMEM supplemented with 2 mM L-glutamine and 10% FBS, and ES-2 cells were cultured in McCoy's 5A medium supplemented with 1.5 mM L-glutamine and 10% FBS. Transfection was performed using Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's instructions. Cells were harvested for analysis 24-48 h after transfection. Target-specific 20-25 nucleotide small interfering RNAs (siRNAs) for human PP1alpha and control siRNA were purchased from Santa Cruz (CA, USA) and siRNA transfection was also performed using Lipofectamine 2000.
###end p 13
###begin title 14
Analysis of cell cycle distribution by flow cytometry
###end title 14
###begin p 15
###xml 164 166 164 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
Cells were harvested by trypsinization, fixed in ice-cold methanol, and subjected to propidium iodide staining and flow cytometric analysis as described previously 32.
###end p 15
###begin title 16
Western analysis
###end title 16
###begin p 17
###xml 232 237 <span type="species:ncbi:9606">human</span>
###xml 300 305 <span type="species:ncbi:10090">mouse</span>
Cells were harvested by trypsinization and lysed in RIPA buffer supplemented with protease inhibitors. Cell lysates containing ~100 mug of protein were subjected to 4-12% SDS-PAGE, followed by Western analysis. Antibodies used were human BRCA1 antibody Ab-1 (MS110) (Calbiochem, San Diego, CA, USA), mouse Brca1 M-20, PP1alpha C-19, Rad51 H-92 antibodies (Santa Cruz), and gamma-tubulin antibody GTU-88 (Sigma, St Louis, MO, USA). Quantitative analysis was performed using Quantity One software (BioRad, Hercules, CA, USA).
###end p 17
###begin title 18
Cell survival assay
###end title 18
###begin p 19
###xml 205 208 205 208 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">137</sup>
Cell survival was measured by colony formation. One day after transfection, 500 or 1000 cells were seeded in T-25 flasks. The next day, cells were either left untreated (C) or exposed to 5 Gy of IR from a 137Cs source (Sheperd Mark I 30-1 Irradiator) at a dose rate of ~110 cGy/min. Two weeks after IR treatment, colonies were fixed in cold methanol and stained with Giemsa. Colonies with at least 50 cells were then scored. Relative cell survival was calculated as the ratio of colony numbers in irradiated and untreated groups (IR/C).
###end p 19
###begin title 20
Immunofluorescence staining
###end title 20
###begin p 21
###xml 470 471 469 470 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 488 490 487 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 552 554 551 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 555 557 554 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">33</xref>
###xml 587 593 <span type="species:ncbi:9986">rabbit</span>
###xml 720 726 <span type="species:ncbi:9986">rabbit</span>
Cells were seeded into 4-well or 8-well chamber slides. The next day, cells were either left untreated or treated with 100 muM of 5-fluorodeoxyuridine (5-FUdR) or irradiated with 5 Gy of IR. After 24 h-treatment in 5-FUdR or 3 h, 6 h and 12 h after exposure to IR, cells were fixed on ice for 30 min in PBS-buffered 3% paraformaldehyde/2% sucrose solution and permeabilized for 5 min in cold Triton buffer (0.5% Triton X-100 in 20 mM HEPES, pH 7.4, 50 mM NaCl, 3 mM MgCl2, 300 mM sucrose)27. Antibody incubation was carried out as described previously 32,33. Primary antibody used was a rabbit polyclonal anti-Rad51 (1:100 to 1:200 dilution, Santa Cruz) and secondary antibody used was FITC or Texas red-conjugated anti-rabbit at a dilution of 1:200. All slides were counter-stained with DAPI and mounted with antifade (Invitrogen). Approximately 500 cells were scored and the percentages of cells with at least ten Rad51 nuclear foci were calculated.
###end p 21
###begin title 22
###xml 0 5 <span type="species:ncbi:302767">Comet</span>
Comet assay
###end title 22
###begin p 23
###xml 64 69 <span type="species:ncbi:302767">comet</span>
###xml 205 210 <span type="species:ncbi:302767">Comet</span>
###xml 324 329 <span type="species:ncbi:302767">comet</span>
###xml 434 439 <span type="species:ncbi:302767">comet</span>
Cells were treated with IR (5 Gy) and subjected to the alkaline comet assay (single-cell gel electrophoresis) 24 h after irradiation according to the manufacturer's protocol (Trevigen, Gaithersburg , MD). Comet images were captured using a fluorescence microscope with a 20x objective (Carl Zeiss Inc., Chester, VA) and the comet tail moment (an index of DNA damage calculated as the product of tail length and fraction of DNA in the comet tail) was evaluated using Cometscore version 1.5 software (AutoComet.com). At least 50 cells were analyzed for each sample in each experiment to calculate the mean tail moment.
###end p 23
###begin title 24
Homologous recombination assay
###end title 24
###begin p 25
###xml 308 310 303 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 328 334 323 329 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pDT220</sup>
###xml 365 370 360 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EcoRV</italic>
###xml 496 502 491 497 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pDT220</sup>
###xml 589 592 584 587 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sce</italic>
###xml 1202 1203 1180 1181 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
To generate cell clones carrying a substrate plasmid for the HR assay, 780 cells were transfected with 1 mug of linearized pDT220 and stable cells were selected with 5 microg/ml of puromycin. Southern blot analysis was used to identify cell clones carrying a single copy of the pDT220 substrate as described 12. A cell clone 780pDT220, which showed two bands after EcoRV digestion (an indication of single copy insertion of pDT220), was selected for the HR assay. To determine chromosomal HR, 780pDT220 cells were co-transfected with either wild-type or mutant pBRCA1GFP and either pCMV-I-SceI or a control vector in 60-mm dishes. Cells were trypsinized and transferred to 100-mm dishes two days after transfection, and were allowed to attach to the dishes for one day. Cells were then selected with XHATM (250 microg/ml xanthine, 13.6 microg/ml hypoxanthine, 0.17 microg/ml aminopterin, 3.87 microg/ml thymidine, and 10 mug/ml mycophenolic acid)(Sigma) for three weeks. Colonies were fixed and stained with Giemsa. XHATM-resistant colonies (at least 50 cells per colony) were quantified. The HR frequency was calculated as the number of resistant colonies divided by the number of cells seeded (5 x 105 in each 100-mm dish).
###end p 25
###begin title 26
Non-homologous end-joining assay
###end title 26
###begin p 27
###xml 77 80 77 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hyg</italic>
###xml 197 198 197 198 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
780 cells were plated in 6-well plates, and co-transfected with a linearized hyg expression vector and wild-type or mutant BRCA1GFP expression vector the next day. Cells were trypsinized and 5 x 105 cells were transferred into 100-mm dishes 24 h after transfection and subjected to selection one day later with 500 mug/ml hygromycin B for 2-3 weeks. Colonies were stained with Giemsa and counted. The NHEJ frequency was calculated as the number of resistant colonies divided by the number of cells seeded.
###end p 27
###begin title 28
Statistical analysis
###end title 28
###begin p 29
###xml 46 47 44 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 104 105 102 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Data were presented as mean +/- SD. Two-sided t-tests were used to assess the significance of the data. P-values < 0.05 were considered statistically significant (marked with " * " in the figures).
###end p 29
###begin title 30
3. Results
###end title 30
###begin title 31
###xml 93 98 <span type="species:ncbi:10090">mouse</span>
A functional PP1-binding motif is important for BRCA1 to enhance survival of Brca1-deficient mouse mammary tumor cells after DNA damage
###end title 31
###begin p 32
###xml 242 244 242 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 301 304 301 304 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">898</sup>
###xml 308 311 308 311 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">901</sup>
###xml 374 379 374 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 397 402 397 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
###xml 402 409 402 409 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8710;11/&#8710;11</sup>
###xml 445 447 445 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 125 130 <span type="species:ncbi:9606">human</span>
###xml 411 416 <span type="species:ncbi:10090">mouse</span>
We previously demonstrated that transient expression of wild-type but not PP1-binding motif mutated (F901A) or deleted (DEL) human BRCA1GFP protein increased cell survival after DNA damage in a BRCA1-deficient breast cancer cell line HCC1937 19. Because the coding sequences for the PP1-binding motif 898KVTF901 is located in exon 11, we sought to confirm this finding in a Brca1 exon 11-deleted (Brca1∆11/∆11) mouse mammary tumor cell line 780 31 and study the underlying mechanisms.
###end p 32
###begin p 33
###xml 70 72 70 72 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 73 75 73 75 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B35">35</xref>
###xml 245 246 245 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1</xref>
###xml 868 869 868 869 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1</xref>
###xml 21 26 <span type="species:ncbi:10090">mouse</span>
###xml 407 412 <span type="species:ncbi:10090">mouse</span>
###xml 762 767 <span type="species:ncbi:9606">human</span>
The full-length (FL) mouse Brca1 protein consists of 1812 amino acids 34,35. Deletion of exon 11 leads to an in-frame loss of nucleotide sequences encoding 1105 amino acids and results in a truncated protein of 707 amino acids. As shown in Fig. 1A, 780 cells only expressed a truncated, but not a FL Brca1 protein detected by Western blot analysis using an antibody M-20, which recognizes the C-terminus of mouse Brca1. Transfection efficiency in 780 was determined using a green fluorescent protein (GFP) expression vector pEGFP-N1 and was in the range of 50-75%, which was much better than the transfection efficiency in HCC1937 cells. Expression of wild-type and mutant (F901A and DEL) BRCA1GFP proteins in 780 cells was monitored by Western analysis using a human BRCA1 antibody MS110 for every transfection experiment and the expression levels were similar (Fig. 1A). Transient expression of wild-type or mutant BRCA1GFP protein in 780 cells was consistent and did not change cell cycle distribution; whereas, protein expression in stable cell clones tended to diminish over time (data not shown). Therefore, we performed the functional assays using transiently transfected cells.
###end p 33
###begin p 34
###xml 327 328 319 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1</xref>
###xml 506 507 498 499 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 529 530 521 522 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 586 591 578 583 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 733 735 725 727 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B36">36</xref>
###xml 996 997 988 989 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1031 1032 1023 1024 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1124 1126 1116 1118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
We next examined whether expression of wild-type, F901A or DEL mutant BRCA1GFP affected survival of 780 cells after exposure to gamma-radiation. Transfected 780 cells were treated with 5 Gy of IR or without irradiation (C), and cell survival was measured by colony formation two weeks after gamma-irradiation. As shown in Fig. 1B, relative cell survival (IR/C) was 8.5% in empty vector-transfected cells, and was significantly increased to 14.3% (a ~70% increase) in wild-type pBRCA1GFP-transfected cells (P = 0.00014, two-sided t test). Our data was comparable to the report by Scully et al., which demonstrated that expression of wild-type BRCA1 increased relative cell survival by 50-100% in HCC1937 cells exposed to 3-4 Gy of IR 36. In contrast, expression of mutant BRCA1GFP, F901A and DEL, resulted in 8.6% and 7.9% relative cell survival respectively, which were similar to empty vector-transfected cells and significantly lower than the survival in wild-type pBRCA1GFP-transfected cells (P = 0.000295, F901A vs. wild-type; P = 0.00017, DEL vs. wild-type). Thus, consistent with our previous finding in HCC1937 cells 19, reconstitution of F901A or DEL mutant BRCA1 protein in Brca1-deficient 780 cells did not enhance survival after gamma-irradiation.
###end p 34
###begin title 35
Mutation of the PP1-binding motif in BRCA1 affects its DNA repair function
###end title 35
###begin p 36
###xml 593 594 593 594 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">2</xref>
###xml 955 957 955 957 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 1221 1222 1217 1218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">2</xref>
###xml 1629 1630 1625 1626 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">2</xref>
BRCA1 phosphorylation by checkpoint kinases in response to DNA damage is involved in the recruitment of DNA repair proteins including Rad51 to DNA lesions. Rad51 focus formation in the nucleus increases after DNA damage and serves as an indication of DNA repair. To determine whether the PP1-binding motif was critical for BRCA1 function in DNA repair, 780 cells were transfected with an empty vector, or pBRCA1GFP (wild-type, F901A, or DEL), left untreated (C) or treated with 5 Gy of IR, and subjected to immunofluorescence staining of Rad 51 at various time points after IR treatment. Fig. 2A shows a control cell with no Rad51 foci and an IR-treated cell with multiple nuclear Rad51 foci. Green fluorescence represents the Rad51 signal. The GFP signal of BRCA1GFP was undetectable because it was quenched in the fusion proteins. Quantitative analysis revealed that the percentage of cells with Rad51 foci (defined as cells with at least 10 Rad51 foci)28 increased dramatically after exposure to IR, and the increase was significantly higher in wild-type pBRCA1GFP-transfected cells (45.5%) than empty vector (20.0%), pBRCA1GFPF901A (25.8%), or pBRCA1GFPDEL-transfected cells (26.0%) 3 h after gamma-irradiation (Fig. 2B). The percentage of cells with Rad51 foci declined 6 h and 12 h after IR. Nevertheless, wild-type BRCA1GFP expressing cells still showed a significantly higher percentage of cells with Rad51 foci compared to others 6 h after IR. A similar trend was observed at 12 h after IR treatment, although the difference between wild-type and mutant BRCA1GFP expressing cells was not statistically significant (Fig. 2B).
###end p 36
###begin p 37
###xml 291 292 291 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3</xref>
###xml 460 461 460 461 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 13 18 <span type="species:ncbi:302767">comet</span>
###xml 174 179 <span type="species:ncbi:302767">comet</span>
###xml 256 261 <span type="species:ncbi:302767">comet</span>
The alkaline comet assay was also performed to measure DNA strand breaks induced by IR in 780 cells expressing wild-type and mutant BRCA1GFP. DNA damage was indicated by the comet tail moment, which is the product of tail length and fraction of DNA in the comet tail. As illustrated in Fig. 3, 24 h after exposure to 5 Gy of IR, empty vector-transfected 780 cells showed a tail moment of 4.03. Expression of wild-type BRCA1GFP reduced the tail moment to 0.84 (P = 0.014). In contrast, mutant BRCA1GFP (F901A and DEL) expressing cells displayed tail moments of 3.65 and 3.06, which were not significantly different from empty vector-transfected cells. Thus, expression of wild-type but not mutant BRCA1GFP enhanced DNA repair in 780 cells.
###end p 37
###begin p 38
###xml 74 79 <span type="species:ncbi:302767">comet</span>
Taken together, results from both the Rad51 focus formation assay and the comet assay provide strong evidence to support that the PP1-binding motif in BRCA1 is important for its DNA repair function.
###end p 38
###begin title 39
Interaction with PP1alpha is important for BRCA1 to recruit Rad51 to sites of DNA damage
###end title 39
###begin p 40
###xml 104 106 104 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B37">37</xref>
It has been reported that BRCA1 is required for the formation of Rad51 subnuclear foci after DNA damage 37. We then tested whether interaction of BRCA1 with PP1alpha affected subcellular redistribution of BRCA1 and Rad51 after DNA damage. 5-FUdR, which showed a similar effect as IR on Rad51 focus formation, was used to induce DNA damage.
###end p 40
###begin p 41
###xml 541 542 541 542 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">4</xref>
###xml 836 837 835 836 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">4</xref>
###xml 1194 1195 1193 1194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">4</xref>
###xml 1272 1273 1271 1272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">4</xref>
###xml 1356 1357 1355 1356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">4</xref>
As mentioned earlier, when GFP was fused to the carboxy terminus of BRCA1, the green fluorescence of the fusion protein (BRCA1GFP) was greatly quenched. In order to improve the green fluorescent signal of the fusion proteins, we constructed a series of wild-type and mutant GFPBRCA1 expression vectors by inserting the BRCA1 coding sequences downstream from the GFP coding sequences using the pGFP-C3 vector. This series of expression vectors worked similarly as the pBRCA1GFP vectors in functional assays (data not shown). As shown in Fig. 4A, when expressed in COS-7 cells, wild-type GFPBRCA1 protein frequently formed large nuclear GFP foci after cells were treated with 100 muM of 5-FUdR for 24 h, whereas, mutant proteins usually appeared as small foci. The difference was not due to variations in GFPBRCA1 expression levels (Fig. 4B), but might be because mutant proteins were less capable to redistribute to DNA damage sites. Indeed, quantitative analysis revealed that more wild-type GFPBRCA1 expressing cells displayed 10 or more nuclear GFP foci after 5-FUdR treatment (19.1%) than mutant GFPBRCA1 expressing cells (6.7% and 8.8% respectively for F901 and DEL) as illustrated in Fig. 4C. Unlike GFPBRCA1 proteins, GFP alone did not form nuclear foci (EV in Fig. 4A). Interestingly, both wild-type and mutant GFPBRCA1 colocalized with Rad51 (Fig. 4A), suggesting that the mutation does not affect BRCA1 interaction with Rad51.
###end p 41
###begin p 42
###xml 361 362 349 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">5</xref>
###xml 383 384 371 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">5</xref>
###xml 649 650 631 632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">5</xref>
###xml 1029 1030 1003 1004 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">5</xref>
###xml 52 57 <span type="species:ncbi:9606">human</span>
We also knocked down PP1alpha in a BRCA1-proficient human ovarian cancer cell line ES-2 by siRNA and measured the formation of Rad51 foci after 5-FUdR treatment. Western analysis indicated that PP1alpha siRNA transfection resulted in more than a 50% decrease in PP1alpha protein level, while BRCA1 and Rad51 protein levels were not significantly affected (Fig. 5A). As shown in Fig. 5B, quantitative analysis revealed that 42.7% of control (C) siRNA-transfected cells had Rad51 foci (defined as cells with >/= 10 Rad51 foci), whereas only 19.4% of PP1alpha siRNA-transfected cells displayed Rad51 foci after 5-FUdR treatment. As illustrated in Fig. 5C, PP1alpha siRNA transfection did not significantly change cell cycle distribution, excluding the possibility that decrease of cells with Rad51 foci by knockdown of PP1alpha was simply due to a cell cycle effect. Since expression of both BRCA1 and Rad51 is cell cycle-dependent and is induced in the S phase, the result from cell cycle analysis was consistent with data in Fig. 5A that showed similar expression levels of BRCA1 and Rad51 in C and PP1alpha siRNA-transfected cells.
###end p 42
###begin p 43
Altogether, these data indicate that interaction of BRCA1 with PP1alpha is important for proper relocation of BRCA1 and Rad51 to DNA damage sites, and consequently is important for the DNA repair function of BRCA1.
###end p 43
###begin title 44
Promotion of homologous recombination and suppression of non-homologous end-joining by BRCA1 are partially impaired when the PP1-binding motif in BRCA1 is mutated
###end title 44
###begin p 45
###xml 115 117 115 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
It has been reported that BRCA1 enhances error-free HR and inhibits error prone NHEJ to ensure accurate DNA repair 12. Since DNA repair function of BRCA1 was impaired by mutation of the PP1-binding motif, we next assessed whether BRCA1 activities in HR and NHEJ were affected by the mutation.
###end p 45
###begin p 46
###xml 68 74 68 74 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pDT220</sup>
###xml 197 199 197 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 281 284 281 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">gpt</italic>
###xml 345 348 345 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sce</italic>
###xml 504 507 504 507 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sce</italic>
###xml 583 586 583 586 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">gpt</italic>
###xml 686 692 686 692 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pDT220</sup>
###xml 745 748 745 748 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sce</italic>
###xml 951 952 951 952 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">6</xref>
###xml 1018 1020 1018 1020 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-6</sup>
###xml 1153 1155 1153 1155 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-5</sup>
###xml 1261 1263 1261 1263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 1308 1311 1308 1311 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sce</italic>
###xml 1357 1359 1357 1359 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-6</sup>
###xml 1434 1436 1434 1436 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-4</sup>
###xml 1483 1484 1483 1484 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1552 1555 1552 1555 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sce</italic>
###xml 1591 1594 1591 1594 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-5 </sup>
###xml 1606 1608 1606 1608 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-5</sup>
###xml 1686 1687 1686 1687 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1852 1855 1852 1855 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sce</italic>
To perform the HR assay, we established a stable 780 cell clone (780pDT220) with a single copy of the linearized pDT220 plasmid DNA integrated in the genome as a substrate for DSB induction and HR 12. The recombination substrate pDT220 contains two mutated copies of the bacterial gpt gene. The upstream copy is inactivated by insertion of an I-SceI recognition site, and the downstream copy has a gene-inactivating 3' deletion in the reverse orientation. DSB induction by transient transfection of an I-SceI expression vector can lead to gene conversion that generates a functional gpt gene and confers resistance to XHATM. To assess the effect of wild-type and mutant BRCA1 on HR, 780pDT220 cells were co-transfected with pBRCA1GFP and pCMV-I-SceI. Recombinants were detected by the formation of XHATM-resistant colonies and the HR frequency was calculated as the number of resistant colonies divided by the number of cells seeded. As shown in Fig. 6A, the spontaneous HR frequency was in the range of 1.33-3.67 x 10-6 in empty vector or mutant pBRCA1GFP-transfected cells, and appeared to be higher in wild-type BRCA1GFP expressing cells at 1.57 x 10-5. Elevated spontaneous HR frequency was also observed in HCC1937 cells reconstituted with wild-type BRCA1 12. In the presence of DSBs generated by the I-SceI endonuclease, the HR frequency was 4.25 x 10-6 in empty vector-transfected cells, but increased dramatically to 1.05 x 10-4 in wild-type pBRCA1GFP-transfected 780 cells (P < 0.05). Expression of mutant BRCA1GFP F901A and DEL resulted in I-SceI-induced HR frequencies of 6.6 x 10-5 and 5.7 x 10-5, which were ~50% of the frequency in cells expressing the wild-type protein (P < 0.05, mutant vs. wild-type). Thus, mutation of the PP1-binding motif significantly reduced but not completely abolished the effect of BRCA1 on the promotion of I-SceI-induced HR.
###end p 46
###begin p 47
###xml 105 108 105 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hyg</italic>
###xml 322 323 322 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">6</xref>
###xml 396 398 396 398 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-4</sup>
###xml 467 469 467 469 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-4</sup>
###xml 543 544 543 544 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 634 636 634 636 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-4</sup>
###xml 650 652 650 652 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-4</sup>
###xml 746 747 746 747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">6</xref>
###xml 802 804 802 804 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
We next determined error-prone NHEJ by measuring random integration of a linearized plasmid carrying the hyg gene. 780 cells were co-transfected with the linearized plasmid and wild-type or mutant pBRCA1GFP, and subjected to hygromycin selection. Colony formation was scored 2-3 weeks after transfection. As shown in Fig. 6B, the NHEJ frequency in empty vector-transfected 780 cells was 1.85 x 10-4. The frequency was slightly suppressed with a frequency of 1.45 x 10-4 (78% of the empty vector control) when wild-type BRCA1GFP was expressed (P < 0.05). The frequencies in cells expressing mutant BRCA1GFP F901A and DEL were 1.74 x 10-4 and 1.68 x 10-4, which were statistically different from that in wild-type pBRCA1GFP-transfected cells (Fig. 6B). This result indicates that unlike in HCC1937 cells 12, BRCA1 only has a minor effect on suppressing NHEJ in 780 cells and mutation of the PP1-binding motif may also compromise this activity.
###end p 47
###begin p 48
These data indicate that the PP1-binding motif in BRCA1 may play a role in enhancing DNA repair through promoting error-free HR and to a lesser extent suppressing error-prone NHEJ.
###end p 48
###begin title 49
4. Discussion
###end title 49
###begin p 50
###xml 208 209 208 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 210 211 210 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
Increasing evidence support the notion that BRCA1 plays a role as a sensor and/or an effector in the DNA damage repair pathway and phosphorylation of BRCA1 by checkpoint kinases is critical for this function 1,2. Here we provide the first evidence to show that interaction with PP1alpha is also important for BRCA1 function in DNA repair.
###end p 50
###begin p 51
###xml 144 149 <span type="species:ncbi:10090">mouse</span>
###xml 292 297 <span type="species:ncbi:302767">comet</span>
In this study, we show that mutant BRCA1 proteins lacking a functional PP1-binding motif are defective in enhancing survival of Brca1-deficient mouse mammary tumor cells after DNA damage at least in part due to an impaired DNA repair function as demonstrated by the Rad51 focus formation and comet assays. We also found that PP1-binding motif-mutated BRCA1 did not relocalize as efficiently as wild-type BRCA1 to sites of DNA lesions. Consequently, the ability of BRCA1 to recruit Rad51 to the DNA lesions was also affected when the PP1-binding site was mutated. Knockdown of PP1alpha in BRCA1-proficient cells by siRNA also significantly reduced the percentage of cells with Rad51 foci in response to DNA damage. Altogether, these results indicate that interaction with PP1alpha is important for the BRCA1 function in DNA repair partly by modulating subnuclear redistribution of Rad51 after DNA damage.
###end p 51
###begin p 52
###xml 119 121 119 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 436 438 432 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 515 517 511 513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 752 754 748 750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 808 810 800 802 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 317 322 <span type="species:ncbi:10090">mouse</span>
BRCA1 S988 phosphorylation regulates the repair of DNA DSBs by promoting error-free HR and inhibiting error-prone NHEJ 12. We demonstrate here that mutation of the PP1-binding motif compromises BRCA1 activities in enhancing error-free HR and to a lesser extent suppressing error-prone NHEJ assayed in Brca1-deficient mouse mammary tumor cells, which is consisitent with our previous finding that PP1alpha regulates S988 phsophorylation 18. However, the effect was not as dramatic as S988A mutation in HCC1937 cells 12. It is not clear whether the PP1-binding site in BRCA1 is also important for other DNA repair mechanisms, such as nucleotide-excision repair and error-free NHEJ. Phosphorylation of BRCA1 S1423 is important for G2/M checkpoint control 11. Since PP1alpha also regulates S1423 phosphorylation 19, it is possible that mutation of the PP1-binding site may affect G2/M checkpoint function of BRCA1. This possibility is currently under investigation.
###end p 52
###begin p 53
###xml 52 54 52 54 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 64 72 64 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 168 170 160 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B38">38</xref>
The PP1-binding motif is common to all PP1 isoforms 14. Indeed, in vitro evidence indicates that BRCA1 also interacts with PP1gamma and PP1delta (Hsu, unpublished data)38. Thus, it is likely that interaction with PP1, other than PP1alpha, is also important for BRCA1 function. Future investigation is required to provide further supporting evidence.
###end p 53
###begin p 54
PP1-binding motif mutated BRCA1 is defective in DNA repair implying that dephosphorylation of BRCA1 may be required for proper DNA damage signaling or DNA repair at some point after DNA damage, emphasizing that proper phosphorylation/dephosphorylation of multiple serine residues in BRCA1 is important for BRCA1 function. Alternatively, BRCA1 may serve as a regulatory subunit for PP1 and target PP1 to other proteins whose dephosphorylation is crucial for the DNA damage repair process. These two possibilities may not be mutually exclusive, and will be investigated in our future study.
###end p 54
###begin p 55
###xml 26 31 26 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 374 380 374 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPP1CA</italic>
###xml 536 538 532 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B39">39</xref>
###xml 632 637 624 629 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 389 394 <span type="species:ncbi:9606">human</span>
Interestingly, a missense BRCA1 mutation (K898E) has been found in the PP1-binding region. The disease relevance of this mutation is still unknown (the Breast Cancer Information Core database). Nonetheless, the presence of a germline mutation that may affect BRCA1 binding with PP1 further strengthens the biological significance of our finding. We have also found that the PPP1CA gene on human chromosome 11q13, which encodes the catalytic subunit of PP1alpha, is amplified and overexpressed in oral squamous cell carcinoma cell lines 39, suggesting a role of PP1alpha deregulation in tumor development and progression. Given that BRCA1 mutations only account for a small proportion of breast and ovarian cancers, deregulation of PP1alpha or other PP1 isoforms may also contribute to breast and ovarian tumorigenesis. Thus, our finding lays the foundation for additional investigation regarding the involvement of PP1 in cancer development. Furthermore, understanding the molecular mechanisms underlying the regulation of BRCA1 function by PP1 may provide new targets for the development of novel cancer therapeutics.
###end p 55
###begin p 56
###xml 62 65 62 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sce</italic>
We thank Dr. Xia Fen for providing plasmids pDT220 and pCMV-I-SceI, Dr. Hubert Tse for help with cell irradiation, and Katherine Klingensmith for technical assistance. Young-Mi Yu was supported partly by the Magee-Womens Research Institute Postdoctoral Fellowship. This study was supported by National Cancer Institute Grant R01CA111436 and funds from the National Taiwan University (to LCH).
###end p 56
###begin article-title 57
BRCA1 and BRCA2: 1994 and beyond
###end article-title 57
###begin article-title 58
Tracing the network connecting BRCA and Fanconi anaemia proteins
###end article-title 58
###begin article-title 59
BRCA1: cell cycle checkpoint, genetic instability, DNA damage response and cancer evolution
###end article-title 59
###begin article-title 60
BRCA1 is a 220-kDa nuclear phosphoprotein that is expressed and phosphorylated in a cell cycle-dependent manner
###end article-title 60
###begin article-title 61
BRCA1 is a cell cycle-regulated nuclear phosphoprotein
###end article-title 61
###begin article-title 62
Requirement of ATM-dependent phosphorylation of Brca1 in the DNA damage response to double-strand breaks
###end article-title 62
###begin article-title 63
Role for ATM in DNA damage-induced phosphorylation of BRCA1
###end article-title 63
###begin article-title 64
Ataxia telangiectasia mutated (ATM) kinase and ATM and Rad3 related kinase mediate phosphorylation of Brca1 at distinct and overlapping sites
###end article-title 64
###begin article-title 65
Functional interactions between BRCA1 and the checkpoint kinase ATR during genotoxic stress
###end article-title 65
###begin article-title 66
hCds1-mediated phosphorylation of BRCA1 regulates the DNA damage response
###end article-title 66
###begin article-title 67
Involvement of Brca1 in S-phase and G(2)-phase checkpoints after ionizing irradiation
###end article-title 67
###begin article-title 68
Chk2 phosphorylation of BRCA1 regulates DNA double-strand break repair
###end article-title 68
###begin article-title 69
Induction of phosphorylation on BRCA1 during the cell cycle and after DNA damage
###end article-title 69
###begin article-title 70
Functional diversity of protein phosphatase-1, a cellular economizer and reset button
###end article-title 70
###begin article-title 71
Ionizing radiation activates nuclear protein phosphatase-1 by ATM-dependent dephosphorylation
###end article-title 71
###begin article-title 72
DNA repair in mononuclear cells: role of serine/threonine phosphatases
###end article-title 72
###begin article-title 73
Recovery from DNA damage checkpoint arrest by PP1-mediated inhibition of Chk1
###end article-title 73
###begin article-title 74
Regulation of BRCA1 phosphorylation by interaction with protein phosphatase 1alpha
###end article-title 74
###begin article-title 75
Identification and functional characterization of a PP1-binding site in BRCA1
###end article-title 75
###begin article-title 76
Roles of BRCA1 in DNA damage repair: a link between development and cancer
###end article-title 76
###begin article-title 77
BRCA1 induces DNA damage recognition factors and enhances nucleotide excision repair
###end article-title 77
###begin article-title 78
###xml 107 112 <span type="species:ncbi:9606">human</span>
BRCA1 and BRCA2 are necessary for the transcription-coupled repair of the oxidative 8-oxoguanine lesion in human cells
###end article-title 78
###begin article-title 79
###xml 39 44 <span type="species:ncbi:10090">mouse</span>
Cell cycle-dependent expression of the mouse Rad51 gene in proliferating cells
###end article-title 79
###begin article-title 80
###xml 34 39 <span type="species:ncbi:9606">human</span>
S phase specific formation of the human Rad51 protein nuclear foci in lymphocytes
###end article-title 80
###begin article-title 81
Association of BRCA1 with Rad51 in mitotic and meiotic cells
###end article-title 81
###begin article-title 82
###xml 47 52 47 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
###xml 57 62 57 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA2</italic>
Stable interaction between the products of the BRCA1 and BRCA2 tumor suppressor genes in mitotic and meiotic cells
###end article-title 82
###begin article-title 83
Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage
###end article-title 83
###begin article-title 84
Association of BRCA1 with the hRad50-hMre11-p95 complex and the DNA damage response
###end article-title 84
###begin article-title 85
The role of the BRCA1 tumor suppressor in DNA double-strand break repair
###end article-title 85
###begin article-title 86
The role of BRCA1 in non-homologous end- joining
###end article-title 86
###begin article-title 87
###xml 97 101 <span type="species:ncbi:10090">mice</span>
Multiple genetic changes are associated with mammary tumorigenesis in Brca1 conditional knockout mice
###end article-title 87
###begin article-title 88
BRCA1 is associated with the centrosome during mitosis
###end article-title 88
###begin article-title 89
Identification of a gamma-tubulin-binding domain in BRCA1
###end article-title 89
###begin article-title 90
###xml 116 120 <span type="species:ncbi:10090">mice</span>
Expression of Brca1 is associated with terminal differentiation of ectodermally and mesodermally derived tissues in mice
###end article-title 90
###begin article-title 91
###xml 29 34 29 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brca1</italic>
The developmental pattern of Brca1 expression implies a role in differentiation of the breast and other tissues
###end article-title 91
###begin article-title 92
Genetic analysis of BRCA1 Function in a defined tumor cell line
###end article-title 92
###begin article-title 93
###xml 38 43 38 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BRCA1</italic>
The breast cancer susceptibility gene BRCA1 is required for subnuclear assembly of Rad51 and survival following treatment with the DNA cross-linking agent cisplatin
###end article-title 93
###begin article-title 94
The interaction of PP1 with BRCA1 and analysis of their expression in breast tumors
###end article-title 94
###begin article-title 95
Gene amplification and overexpression of protein phosphatase 1alpha in oral squamous cell carcinoma cell lines
###end article-title 95
###begin p 96
###xml 554 556 550 552 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 82 87 <span type="species:ncbi:10090">mouse</span>
###xml 161 166 <span type="species:ncbi:9606">human</span>
###xml 201 206 <span type="species:ncbi:10090">mouse</span>
A PP1-binding motif is important for BRCA1 to enhance survival of Brca1-deficient mouse mammary tumor cells after gamma-irradiation. (A) Expression of exogenous human BRCA1GFP and endogenous truncated mouse Brca1 in transiently transfected 780 cells. (B) Cell survival measured by colony formation. 780 cells were transfected with empty vector pEGFP-N1KS- (EV), wild-type pBRCA1GFP (WT), pBRCA1GFPF901A (F901A), and pBRCA1GFPDEL (DEL), followed by exposure to 5 Gy of IR. The assay was performed at least three times and similar results were obtained. * P < 0.05
###end p 96
###begin p 97
Mutation of the PP1-binding motif in BRCA1 affects Rad51 focus formation after gamma-irradiation. (A) A control 780 cell with no Rad51 foci and an IR-treated cell with multiple nuclear Rad51 foci. Green: Rad51, blue: DAPI counterstaining of the nucleus. (B) The percentage of transiently transfected 780 cells with Rad51 foci (defined as cells with >/= 10 Rad51 nuclear foci) at various time points after exposure to 5 Gy of IR. EV, empty vector pEGFP-N1KS-; WT, wild-type pBRCA1GFP; F901A, pBRCA1GFPF901A; DEL, pBRCA1GFPDEL.
###end p 97
###begin p 98
###xml 120 125 <span type="species:ncbi:302767">comet</span>
###xml 200 205 <span type="species:ncbi:302767">comet</span>
Wild-type, but not PP1-non-binding mutant BRCA1 enhances the repair of DNA strand breaks in 780 cells determined by the comet assay. Transfected cells were exposed to 5 Gy of IR and harvested for the comet assay 24 h after irradiation.
###end p 98
###begin p 99
PP1-non-binding mutant BRCA1 proteins are defective in relocalization to DNA damage sites. (A) Formation of GFPBRCA1 and Rad51 nuclear foci in COS-7 cells after 5-FUdR treatment. Cells were fixed and subjected to Rad51 staining. Green: GFP or GFPBRCA1, red: Rad51. (B) Expression of GFPBRCA1 and Rad51 proteins. gamma-Tubulin serves as a loading control. (C) The percentage of cells with >/= 10 GFPBRCA1 nuclear foci induced by 5-FUdR.
###end p 99
###begin p 100
Knockdown of PP1alpha by siRNA reduces Rad51 nuclear foci induced by 5-FUdR. (A) Expression of PP1alpha, BRCA1, and Rad51 in C and PP1alpha siRNA-transfected ES-2 cells. (B) The percentage of ES-2 cells with Rad51 foci (defined as cells with >/= 10 Rad51 nuclear foci) induced by 5-FUdR. (C) Cell cycle distribution of C and PP1alpha siRNA-transfected cells.
###end p 100
###begin p 101
The PP1-binding motif in BRCA1 compromises its DNA repair function at least in part through promoting error-free HR and to a lesser extent suppressing error-prone NHEJ. (A) HR assay. (B) NHEJ assay.
###end p 101

